Monoclonal antibodies against human factor VIII molecular neutralize antihemophilic factor and ristocetin cofactor activities.
- 1 January 1982
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 79 (1) , 183-187
- https://doi.org/10.1073/pnas.79.1.183
Abstract
A series of monoclonal antibodies have been raised against a preparation of the factor VIII/von Willebrand factor molecule. Of the seven hybridomas showing specific activity against the factor VIII molecule in a solid-phase radioimmunoassay, three (F4.55, F4.77, and F4.264) have been shown to partially inhibit ristocetin-induced platelet aggregation and two (F4.115 and F4.415) inhibit the antihemophilic activity of the factor VIII molecule. An additional monoclonal antibody was directed against a contaminant of the factor VIII preparation and is an antifibrinogen antibody.Keywords
This publication has 19 references indexed in Scilit:
- Methods for binding cells to plastic: Application to a solid-phase radioimmunoassay for cell-surface antigensJournal of Immunological Methods, 1979
- IMMUNORADIOMETRIC ASSAY OF PROCOAGULANT FACTOR-VIII ANTIGEN IN PLASMA AND SERUM AND ITS REDUCTION IN HÆMOPHILIAThe Lancet, 1978
- Derivation of specific antibody‐producing tissue culture and tumor lines by cell fusionEuropean Journal of Immunology, 1976
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975
- Studies of the human factor VIII/von Willebrand's factor protein I. Comparison of the protein found in normal, von Willebrand's disease and hemophilia AThrombosis Research, 1975
- MOLECULAR STRUCTURAL STUDIES OF HUMAN FACTOR VIII*Annals of the New York Academy of Sciences, 1975
- Factor VIII, A series of homologous oligomers and a complex of two proteinsThrombosis Research, 1974
- Quantitative Assay of a Plasma Factor Deficient in von Willebrand's Disease that is Necessary for Platelet Aggregation. RELATIONSHIP TO FACTOR VIII PROCOAGULANT ACTIVITY AND ANTIGEN CONTENTJournal of Clinical Investigation, 1973
- Factor VIII Recombination After Dissociation by CaCl 2Proceedings of the National Academy of Sciences, 1973
- The Mode of Action of Antibodies which Destroy Factor VIIIBritish Journal of Haematology, 1972